SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-022988
Filing Date
2021-05-04
Accepted
2021-05-04 07:20:57
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20210331.htm   iXBRL 10-Q 2464806
2 EX-10.1 sage-ex101_175.htm EX-10.1 148929
3 EX-31.1 sage-ex311_6.htm EX-31.1 9328
4 EX-31.2 sage-ex312_7.htm EX-31.2 9279
5 EX-32.1 sage-ex321_8.htm EX-32.1 8635
6 GRAPHIC gmksagnqbviq000001.jpg GRAPHIC 195853
  Complete submission text file 0001564590-21-022988.txt   9054982

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sage-20210331.xsd EX-101.SCH 53232
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20210331_cal.xml EX-101.CAL 42566
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20210331_def.xml EX-101.DEF 208456
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20210331_lab.xml EX-101.LAB 399797
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20210331_pre.xml EX-101.PRE 323613
12 EXTRACTED XBRL INSTANCE DOCUMENT sage-10q_20210331_htm.xml XML 1625661
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 21885984
SIC: 2834 Pharmaceutical Preparations